The fatty acid amide hydrolase (FAAH)

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 66, Issue 2-3, 2002, Pages 201-210

  Deutsch, D G ^a   Ueda, N ^b   Yamamoto, S ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b KAGAWA UNIVERSITY   (Japan)

^c KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; FATTY ACID AMIDASE; PROLINE; SERINE; AMIDASE; AMIDE; ARACHIDONIC ACID DERIVATIVE; ENDOCANNABINOID; FATTY-ACID AMIDE HYDROLASE;

BRAIN; CATALYSIS; CELLULAR DISTRIBUTION; ENZYME ASSAY; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HUMAN; HYDROLYSIS; KNOCKOUT GENE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; RAT; REVIEW; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; GENE DELETION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE;

SUS SCROFA;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; BASE SEQUENCE; CATALYSIS; ENDOCANNABINOIDS; GENE DELETION; HUMANS; MOLECULAR SEQUENCE DATA; POLYUNSATURATED ALKAMIDES; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY;

EID: 0036019388     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0358     Document Type: Article

References (101)

1. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
2. Cellular uptake of anandamide is inhibited by blocking its degradation with FAAH inhibitors
3. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase
4. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells
5. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide
6. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
7. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
8. Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization
9. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide
10. Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain
11. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
12. Microsomal synthesis of fatty acid amides
13. Properties of rat liver N-acylethanolamine amidohydrolase
14. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiopathological relevance
15. Biochemistry of the endogenous ligands of cannabinoid receptors
16. Biosynthesis and inactivation of endocannabinoids: Relevance to their proposed role as neuromodulators
17. Inhibitors of anandamide breakdown
18. The neurobiology and evolution of cannabinoid signalling
19. The fatty acid amide hydrolase (FAAH)
20. Anandamide amidohydrolase (fatty acid amide hydrolase)
21. Fatty acid amide hydrolase: Biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonylglycerol, palmitoylethanolamide and oleamide
22. Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides
23. A sensitive and specific radiochromatographic assay of fatty acid amide hydrolase activity
24. Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase'
25. 14C] as a substrate for anandamide amidase
26. High-performance liquid chromatographic determination of anandamide amidase activity in rat brain microsomes
27. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand
28. Distribution and characterization of anandamide amidohydrolase in mouse brain and liver
29. Determination of anandamide amidase activity using ultraviolet-active amine derivatives and reverse-phase high-performance liquid chromatography
30. A fluorescence displacement assay for the measurement of arachidonoyl ethanolamide (anandamide) and oleoyl amide (octadecenoamide) hydrolysis
31. Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase
32. Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: Identification of the transmembrane domain as a site for oligomerization
33. Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme
34. Anandamide: An endogenous cannabinoid receptor agonist
35. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes
36. Anandamide hydrolysis by human cells in culture and brain
37. Chemical characterization of a family of brain lipids that induce sleep
38. Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase
39. Mechanisms of endocannabinoid inactivation: Biochemistry and pharmacology
40. Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase
41. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: Connections with anandamide
42. Fatty acid amide hydrolase substrate specificity
43. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors
44. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol
45. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors
46. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages
47. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes
48. The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the carmabinoid receptor
49. Alternative pathways of anandamide biosynthesis in rat testes
50. The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine
51. Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis
52. Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine
53. Production and physiological actions of anandamide in the vasculature of the rat kidney
54. Anandamide uptake by human endothelial cells and its regulation by nitric oxide
55. Molecular characterization of human and mouse fatty acid amide hydrolases
56. The uterus is a potential site for anandamide synthesis and hydrolysis: Differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the preimplantation period
57. Fatty-acid amide hydrolase is expressed in the mouse uterus and embryo during the preimplantation period
58. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage
59. Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues
60. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina
61. Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina
62. Evidence for an endocannabinoid system in the central nervous system of the leech Hirudo medicinalis
63. Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues
64. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry
65. A new perspective on cannabinoid signalling: Complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain
66. Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system
67. Structural determinants for recognition and translocation by the anandamide transporter
68. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: Comparison with anandamide
69. Inhibitors of arachidonoyl ethanolamide hydrolysis
70. Inhibition of oleamide hydrolase catalyzed hydrolysis of the endogenous sleep-inducing lipid cis-9-octadecenamide
71. Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: A probe of structural and conformational features contributing to inhibition
72. Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide
73. Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase
74. Brain and peripheral anandamide amidohydrolase and its inhibition by synthetic arachidonate analogues
75. Synthesis and characterization of diazomethylarachidonyl ketone: An irreversible inhibitor of N-arachidonylethanolamine amidohydrolase
76. Inhibition of anandamide hydrolysis in rat brain tissue by (E)-6-(bromomethylene) tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one
77. An endogenous sleep-inducing compound is a novel competitive inhibitor of fatty acid amide hydrolase
78. Effects of anandamide on cannabinoid receptors in rat brain membranes
79. Identification of two serine residues involved in catalysis by fatty acid amide hydrolase
80. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor
81. Methyl arachidonyl fluorophosphonate: A potent irreversible inhibitor of anandamide amidase
82. Cannabinoid properties of methylfluorophosphonate analogs
83. Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides
84. Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids
85. Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship
86. Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen
87. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase
88. Purification, cloning, and primary structure of a new enantiomer-selective amidase from a Rhodococcus strain: Structural evidence for a conserved genetic coupling with nitrile hydratase
89. Study of the amidase signature group
90. Identification of active sites in amidase: Evolutionary relationship between amide bond- and peptide bond-cleaving enzymes
91. Deletion of a proline-rich region and a transmembrane domain in fatty acid amide hydrolase
92. Structure-function studies of anandamide amidase
93. Chemical and mutagenic investigations of fatty acid amide hydrolase: Evidence for a family of serine hydrolases with distinct catalytic properties
94. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
95. Clarifying the catalytic roles of conserved residues in the amidase signature family
96. Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism
97. Conserved chromosomal location and genomic structure of human and mouse fatty-acid amide hydrolase genes and evaluation of clasper as a candidate neurological mutation
98. Characterization of the 5′-sequence of the mouse fatty acid amide hydrolase
99. Oligo-capping: A simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides
100. An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors
101. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance